ANDOVER, Mass., Aug. 8 /PRNewswire-FirstCall/ -- Smith & Nephew’s Endoscopy division today announced the launch of its new DYONICS(R) ARTHROPAK(TM) Customized Procedure Kits, which contain medical devices used in the most common arthroscopic procedures.
The kits are designed to increase operational efficiencies and lower overall costs by helping to reduce the amount of time facility staff spend ordering and pulling supplies, such as cannulae, sterile tubing and arthroscopic resection blades for each procedure. Instead, the surgery center staff simply designates which supplies and devices the kits should contain.
“There are devices we use in almost every procedure,” said Dr. Joseph Abate of Fletcher Allen Health Care in Burlington, Vt. “With the DYONICS ARTHROPAK kit, you open the box and get everything the surgeon will want to use. For the facility, ARTHROPAK kits offer increased efficiency and reduced costs.”
The cost savings can be significant at ambulatory surgery centers (ASCs) where surgeons perform multiple procedures each day.
“We are saving 3 to 5 minutes per procedure, which may not seem like a lot of time,” said Julie Beauchamp, who monitors materials management at Northeast Surgical Care, a multi-specialty surgery center in Newington, N.H. “But in a busy surgery center like ours, when we’re paying staff to assemble all the devices needed for procedures, that saved time translates into saved operating expense.”
Each kit has its own SKU -- or product identifier -- so when the time comes to replenish supplies, the purchasing staff can easily order a new kit instead of individual devices. They can also have a standing order to replenish supplies.
“Smith & Nephew Endoscopy offers a complete range of devices surgeons need for arthroscopic procedures,” said Jerry Goodman, vice president and general manager of Resection. “With the DYONICS ARTHROPAK Customized Procedure Kit, we’ve made it easier for medical facilities to obtain everything they need for their patients, in addition to improving efficiency and containing costs, something that is a concern throughout the medical marketplace.”
About Smith & Nephew:
Smith & Nephew (http://www.smith-nephew.com) is a global medical technology business, specializing in Endoscopy, Orthopaedic Reconstruction, Orthopaedic Trauma and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people’s lives. The company prides itself on the strength of its relationships with its surgeon and professional healthcare customers, with whom its name is synonymous with the highest standards of performance, innovation and trust. The company has more than 8,500 employees and operates in 33 countries around the world and generated sales of nearly $2.6 billion.
This press release contains certain “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our trading margins discussed under “Outlook” are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases “aim”, “plan”, “intend”, “anticipate”, “well-placed”, “believe”, “estimate”, “expect”, “target”, “consider” and similar expressions, are generally intended to identify forward-looking statements. Such forward- looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew’s most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew’s expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Contact: Joe Metzger Smith & Nephew Endoscopy (978) 749-1330
Smith & Nephew
CONTACT: Joe Metzger of Smith & Nephew Endoscopy, +1-978-749-1330
Web site: http://www.smith-nephew.com/
